CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Total Angi Inc. Shareholders' Equity	Common Stock Class A Common Stock $0.001 Par Value	Common Stock Class B Convertible Common Stock $0.001 Par Value	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Noncontrolling Interests	Redeemable Noncontrolling Interests
Balance at beginning of period at Dec. 31, 2020										$ 26,364
Increase (Decrease) in Redeemable Noncontrolling Interests
Net (loss) earnings										(23)
Other comprehensive (income) loss										515
Purchase of redeemable noncontrolling interests										(28,318)
Adjustment of redeemable noncontrolling interests to redemption amount										1,462
Balance at end of period at Dec. 31, 2021										$ 0
Balance at beginning of period at Dec. 31, 2020	$ 1,282,857	$ 1,272,290	$ 94	$ 422	$ 1,379,469	$ 9,749	$ 4,637	$ (122,081)	$ 10,567
Balance at beginning of period (in shares) at Dec. 31, 2020			94,238	421,862
Increase (Decrease) in Shareholders' Equity
Net (loss) earnings	(70,471)	(71,378)				(71,378)			907
Other comprehensive income (loss)	(1,734)	(1,328)					(1,328)		(406)
Stock-based compensation expense	33,057	33,057			33,057
Issuance of common stock pursuant to stock-based awards, net of withholding taxes	(61,223)	(61,223)	$ 3		(61,226)
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares)			2,919
Issuance of common stock to IAC Inc. pursuant to the employee matters agreement	0		$ 3	$ 157	(3)
Issuance of common stock to IAC Inc. pursuant to the employee matters agreement (in shares)			2,588
Purchase of treasury stock	(35,959)	(35,959)						(35,959)
Purchase of noncontrolling interests	(160)								(160)
Adjustment to noncontrolling interests resulting from the reorganization of a foreign subsidiary	(430)	(430)			(430)
Other	(410)	(410)			(410)
Balance at end of period at Dec. 31, 2021	1,145,527	1,134,619	$ 100	$ 422	1,350,457	(61,629)	3,309	(158,040)	10,908
Balance at end of period (in shares) at Dec. 31, 2021			99,745	422,019
Increase (Decrease) in Shareholders' Equity
Net (loss) earnings	(127,982)	(128,450)				(128,450)			468
Other comprehensive income (loss)	(5,028)	(4,481)					(4,481)		(547)
Stock-based compensation expense	55,891	55,891			55,891
Issuance of common stock pursuant to stock-based awards, net of withholding taxes	(8,627)	(8,627)	$ 3		(8,630)
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares)			3,066
Purchase of treasury stock	(8,144)	(8,144)						(8,144)
Adjustment to noncontrolling interests resulting from the reorganization of a foreign subsidiary	(255)	7,580			7,580				(7,835)
Other	(4)	(4)			(4)
Balance at end of period at Dec. 31, 2022	1,051,378	1,048,384	$ 103	$ 422	1,405,294	(190,079)	(1,172)	(166,184)	2,994
Balance at end of period (in shares) at Dec. 31, 2022			102,811	422,019
Increase (Decrease) in Shareholders' Equity
Net (loss) earnings	(40,311)	(40,940)				(40,940)			629
Other comprehensive income (loss)	2,501	2,359					2,359		142
Stock-based compensation expense	48,388	48,388			48,388
Issuance of common stock pursuant to stock-based awards, net of withholding taxes	(6,288)	(6,288)	$ 4		(6,292)
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares)			4,037
Purchase of treasury stock	(11,099)	(11,099)						(11,099)
Other	(61)	(37)			(37)				(24)
Balance at end of period at Dec. 31, 2023	$ 1,044,508	$ 1,040,767	$ 107	$ 422	$ 1,447,353	$ (231,019)	$ 1,187	$ (177,283)	$ 3,741
Balance at end of period (in shares) at Dec. 31, 2023			106,848	422,019